Goldman Sachs’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-812,927
| Closed | -$2.47M | – | 5330 |
|
2024
Q4 | $2.47M | Sell |
812,927
-350,444
| -30% | -$1.07M | ﹤0.01% | 3336 |
|
2024
Q3 | $6.04M | Buy |
1,163,371
+229,753
| +25% | +$1.19M | ﹤0.01% | 2624 |
|
2024
Q2 | $2.4M | Buy |
933,618
+390,169
| +72% | +$1M | ﹤0.01% | 3093 |
|
2024
Q1 | $2.67M | Sell |
543,449
-240,179
| -31% | -$1.18M | ﹤0.01% | 3017 |
|
2023
Q4 | $6.89M | Sell |
783,628
-361,016
| -32% | -$3.17M | ﹤0.01% | 2356 |
|
2023
Q3 | $13.1M | Sell |
1,144,644
-596,258
| -34% | -$6.84M | ﹤0.01% | 1798 |
|
2023
Q2 | $44.1M | Buy |
1,740,902
+642,612
| +59% | +$16.3M | 0.01% | 1026 |
|
2023
Q1 | $35.4M | Sell |
1,098,290
-113,570
| -9% | -$3.66M | 0.01% | 1122 |
|
2022
Q4 | $22.4M | Buy |
1,211,860
+72,052
| +6% | +$1.33M | 0.01% | 1523 |
|
2022
Q3 | $30.8M | Buy |
1,139,808
+310,883
| +38% | +$8.39M | 0.01% | 1281 |
|
2022
Q2 | $11.5M | Buy |
828,925
+172,369
| +26% | +$2.38M | ﹤0.01% | 2020 |
|
2022
Q1 | $12.8M | Sell |
656,556
-149,476
| -19% | -$2.91M | ﹤0.01% | 2038 |
|
2021
Q4 | $13.2M | Buy |
806,032
+211,332
| +36% | +$3.45M | ﹤0.01% | 2069 |
|
2021
Q3 | $16.6M | Buy |
594,700
+129,264
| +28% | +$3.6M | ﹤0.01% | 1890 |
|
2021
Q2 | $13.8M | Buy |
465,436
+17,721
| +4% | +$525K | ﹤0.01% | 2011 |
|
2021
Q1 | $12.5M | Buy |
447,715
+43,589
| +11% | +$1.22M | ﹤0.01% | 2041 |
|
2020
Q4 | $11.5M | Sell |
404,126
-48,490
| -11% | -$1.37M | ﹤0.01% | 1967 |
|
2020
Q3 | $11.4M | Sell |
452,616
-108,259
| -19% | -$2.72M | ﹤0.01% | 1853 |
|
2020
Q2 | $13.7M | Sell |
560,875
-170,659
| -23% | -$4.17M | ﹤0.01% | 1737 |
|
2020
Q1 | $10.8M | Buy |
731,534
+623,626
| +578% | +$9.23M | ﹤0.01% | 1765 |
|
2019
Q4 | $1.75M | Buy |
107,908
+33,193
| +44% | +$539K | ﹤0.01% | 3014 |
|
2019
Q3 | $971K | Buy |
74,715
+21,030
| +39% | +$273K | ﹤0.01% | 3266 |
|
2019
Q2 | $696K | Sell |
53,685
-58,773
| -52% | -$762K | ﹤0.01% | 3381 |
|
2019
Q1 | $1.77M | Buy |
112,458
+72,996
| +185% | +$1.15M | ﹤0.01% | 3002 |
|
2018
Q4 | $794K | Sell |
39,462
-43,908
| -53% | -$883K | ﹤0.01% | 3231 |
|
2018
Q3 | $2.07M | Sell |
83,370
-52,872
| -39% | -$1.31M | ﹤0.01% | 2862 |
|
2018
Q2 | $3.74M | Buy |
136,242
+77,221
| +131% | +$2.12M | ﹤0.01% | 2561 |
|
2018
Q1 | $1.82M | Buy |
59,021
+32,475
| +122% | +$1M | ﹤0.01% | 2925 |
|
2017
Q4 | $949K | Sell |
26,546
-158,334
| -86% | -$5.66M | ﹤0.01% | 3177 |
|
2017
Q3 | $5.09M | Buy |
184,880
+5,223
| +3% | +$144K | ﹤0.01% | 2339 |
|
2017
Q2 | $4.74M | Sell |
179,657
-368,993
| -67% | -$9.74M | ﹤0.01% | 2310 |
|
2017
Q1 | $11.4M | Buy |
548,650
+141,400
| +35% | +$2.94M | ﹤0.01% | 1791 |
|
2016
Q4 | $8.43M | Sell |
407,250
-18,375
| -4% | -$380K | ﹤0.01% | 1892 |
|
2016
Q3 | $6.9M | Buy |
425,625
+446
| +0.1% | +$7.23K | ﹤0.01% | 2048 |
|
2016
Q2 | $5.78M | Buy |
425,179
+125,123
| +42% | +$1.7M | ﹤0.01% | 2046 |
|
2016
Q1 | $5.24M | Sell |
300,056
-15,770
| -5% | -$275K | ﹤0.01% | 2044 |
|
2015
Q4 | $10.8M | Sell |
315,826
-65,659
| -17% | -$2.24M | ﹤0.01% | 1645 |
|
2015
Q3 | $11.4M | Buy |
381,485
+71,547
| +23% | +$2.13M | ﹤0.01% | 1579 |
|
2015
Q2 | $9.91M | Sell |
309,938
-106,027
| -25% | -$3.39M | ﹤0.01% | 1696 |
|
2015
Q1 | $8.62M | Buy |
415,965
+13,210
| +3% | +$274K | ﹤0.01% | 1746 |
|
2014
Q4 | $6.82M | Sell |
402,755
-22,690
| -5% | -$384K | ﹤0.01% | 1800 |
|
2014
Q3 | $8.22M | Sell |
425,445
-14,257
| -3% | -$276K | ﹤0.01% | 1705 |
|
2014
Q2 | $15M | Buy |
439,702
+196,599
| +81% | +$6.68M | ﹤0.01% | 1414 |
|
2014
Q1 | $7.66M | Buy |
+243,103
| New | +$7.66M | ﹤0.01% | 1729 |
|